Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Caledonian Record
caledonianrecord.com > capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action > article_4818f98b-5a0a-509e-b66b-174cd1925863.html

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action...

1+ mon, 1+ week ago   (163+ words) NEW YORK and NEW ORLEANS, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NasdaqGS: CAPR)…...

Morningstar
morningstar.com > news > pr-newswire > 20/26/0820ny30666 > regn-shareholder-alert-september-14-2026-lead-plaintiff-deadline-in-regeneron-pharmaceuticals-securities-class-action-contact-suewallst

REGN Shareholder Alert: September 14, 2026 Lead Plaintiff Deadline in Regeneron Pharmaceuticals Securities Class Action - Contact SueWallSt

3+ week, 3+ day ago   (684+ words) NEW YORK, Aug. 20, 2026 This Regeneron analyst reaction focuses on analysts' reassessment of the Phase III Fianlimab-Libtayo Study after a protocol amendment raised concerns about statistical significance and potential impact on Regeneron's pipeline and future growth expectations. NEW YORK, Aug. 20, 2026 /PRNewswire…...

TMX Newsfile
newsfilecorp.com > release > 310894 > Regeneron-Pharmaceuticals-Inc.-Notice-of-September-14-2026-Application-Deadline-for-Class-Action-Lawsuit-Contact-Reed-Kathrein-at-Hagens-Berman-Sobol-Shapiro-LLP-Before-Application-Deadline

Regeneron Pharmaceuticals, Inc. Notice of September 14, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline

3+ week, 2+ day ago   (604+ words) August 21, 2026 5:47 PM EDT | Source: Hagens Berman Sobol Shapiro LLP San Francisco, California--(Newsfile Corp. - August 21, 2026) - Hagens Berman Sobol Shapiro LLP alerts investors in Regeneron Pharmaceuticals (NASDAQ: REGN) that a securities class action lawsuit has been filed after its surprising revelations…...

Morningstar
morningstar.com > news > pr-newswire > 20/26/0909ny43229 > levi-korsinsky-reminds-regeneron-pharmaceuticals-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-14-2026-regn

Levi & Korsinsky Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 14, 2026 - REGN

4+ day, 6+ hour ago   (518+ words) III study protocol had been altered to expand the patient population eligible for progression-free survival...

Google News
newsfilecorp.com > release > 310881 > Capricor-Therapeutics-Inc.-Notice-of-September-28-2026-Application-Deadline-for-Class-Action-Lawsuit-Contact-Lewis-Kahn-Esq.-at-Kahn-Swick-Foti-LLC-Before-Application-Deadline

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

3+ week, 2+ day ago   (270+ words) August 21, 2026 4:55 PM EDT | Source: Kahn Swick & Foti, LLC New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 21, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics,…...

TMX Newsfile
newsfilecorp.com > release > 312997 > REGN-10DAY-DEADLINE-ALERT-Regeneron-Pharmaceuticals-Inc.-Investors-Alerted-to-September-14-2026-Lead-Plaintiff-Deadline-in-Class-Action-Lawsuit

REGN 10-DAY DEADLINE ALERT: Regeneron Pharmaceuticals, Inc. Investors Alerted to September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit

1+ week, 2+ day ago   (386+ words) San Francisco, California--(Newsfile Corp. - September 4, 2026) - Hagens Berman Sobol Shapiro LLP alerts investors in Regeneron Pharmaceuticals (NASDAQ:......

TMX Newsfile
newsfilecorp.com > release > 312929 > SEPTEMBER-14-2026-REGN-INVESTOR-DEADLINE-Regeneron-Pharmaceuticals-Inc.-Investors-with-Substantial-Losses-Have-Opportunity-to-Lead-Class-Action-Lawsuit

SEPTEMBER 14, 2026 REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

1+ week, 1+ day ago   (20+ words) San Diego, California--(Newsfile Corp. - September 5, 2026) - The law firm of Robbins Geller Rudman & Dowd LLP announces......

TMX Newsfile
newsfilecorp.com > release > 312931 > 1-WEEK-REGN-INVESTOR-DEADLINE-Regeneron-Pharmaceuticals-Inc.-Investors-with-Substantial-Losses-Have-Opportunity-to-Lead-Class-Action-Lawsuit-Before-September-14-2026-Deadline

1 WEEK REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before September 14, 2026 Deadline

6+ day, 2+ hour ago   (20+ words) San Diego, California--(Newsfile Corp. - September 7, 2026) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers......

TMX Newsfile
newsfilecorp.com > release > 312930 > REGN-INVESTOR-DEADLINE-Regeneron-Pharmaceuticals-Inc.-Investors-with-Substantial-Losses-Have-Opportunity-to-Lead-Class-Action-Lawsuit-Before-September-14-2026-Deadline

REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before September 14, 2026 Deadline

1+ week, 2+ hour ago   (20+ words) San Diego, California--(Newsfile Corp. - September 6, 2026) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers......

TMX Newsfile
newsfilecorp.com > release > 311120 > MVST-IMPORTANT-DEADLINE-ROSEN-A-LEADING-LAW-FIRM-Encourages-Microvast-Holdings-Inc.-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-MVST

MVST IMPORTANT DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Microvast Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MVST

2+ week, 6+ day ago   (187+ words) August 24, 2026 1:23 PM EDT | Source: The Rosen Law Firm PA New York, New York--(Newsfile Corp. - August 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Microvast Holdings, Inc. (NASDAQ: MVST) between April 1, 2025 and March…...

Web

External web results are waiting for the human check. Complete the press-and-hold control above. Google advertising and AI choices remain separate after verification.